Offstream
news

Changes

1. Hungary grants the approval of the CanSino Biologics' Convidecia vaccine based on the interim results of its phase III trial.
   2021-03-22 13:06:13 (First version)
2. Hungary grants the emergency use approval of the CanSino Biologics' Convidecia and Indian Covishield vaccines.
   2021-03-23 00:12:21 (Update)
3. Hungary grants emergency use approval for the CanSino Biologics Convidecia and Indian Covishield vaccines.
   2021-03-23 09:06:19 (Update)
4. Hungary grants emergency use approval for the CanSino Biologics Convidecia and Indian Covishield COVID-19 vaccines.
   (Current version)

Related